LogicBio, CMRI partner to develop next-generation viral vectors

Gene therapy company LogicBio Therapeutics Inc. (NASDAQ:LOGC) and Children's Medical Research Institute (CMRI) (Westmead, Australia) partnered to develop next generation adeno-associated virus (AAV) capsids through their newly launched AAV Development Program.

LogicBio scientific co-founder Leszek Lisowski will co-lead the program alongside Ian Alexander, a professor and head of the Gene Therapy Research Unit at CMRI...